Clenoliximab

From Self-sufficiency
Jump to: navigation, search
Clenoliximab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD4
Identifiers
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Clenoliximab (INN[1]) is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis.[2] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. 1.0 1.1 World Health Organization (1997). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 77" (PDF). WHO Drug Information. 11 (2): 89. 
  2. Hepburn, TW; Totoritis, MC; Davis, CB (2003). "Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis". Rheumatology (Oxford, England). 42 (1): 54–61. doi:10.1093/rheumatology/keg030. PMID 12509613.